| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer (NCT00005026) | Gynecologic Oncology Group | 2000-02-01 |
| Biological Therapy in Treating Patients With Advanced Cancer (NCT00005956) | Duke University | 2000-02-01 |
| Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT00006041) | Memorial Sloan Kettering Cancer Center | 2000-02-01 |
| Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer (NCT00005029) | Gynecologic Oncology Group | 2000-02-01 |
| Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin (NCT00006043) | Memorial Sloan Kettering Cancer Center | 2000-02-01 |
| Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy (NCT00005836) | Gynecologic Oncology Group | 2000-02-01 |
| Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy (NCT00312988) | North Eastern German Society of Gynaecological Oncology | 2000-01-01 |
| Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer (NCT00006454) | AGO Study Group | 1999-12-01 |
| Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer (NCT00102375) | AGO Study Group | 1999-12-01 |
| Vinorelbine and XR9576 to Treat Cancer (NCT00001944) | National Cancer Institute (NCI) | 1999-12-01 |
| Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer (NCT00004909) | Northwestern University | 1999-11-01 |
| Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy (NCT00004166) | Northwestern University | 1999-10-01 |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery (NCT00004895) | Northwestern University | 1999-10-01 |
| Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer (NCT00004206) | University of Leicester | 1999-09-01 |
| Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy (NCT00006453) | AGO Study Group | 1999-09-01 |
| Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer (NCT00102414) | AGO Study Group | 1999-09-01 |
| Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT00003967) | Gynecologic Oncology Group | 1999-09-01 |
| S9912 Combination Chemo in Stage III Ovarian Cancer, (NCT00003896) | SWOG Cancer Research Network | 1999-09-01 |
| Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer (NCT00004934) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 1999-08-01 |
| Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer (NCT00004876) | Cancer Research UK | 1999-08-01 |
| Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma (NCT00005590) | Cancer Research Campaign Clinical Trials Centre | 1999-08-01 |
| Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer (NCT00004177) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 1999-08-01 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer (NCT00005612) | H. Lee Moffitt Cancer Center and Research Institute | 1999-08-01 |
| Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer (NCT00005051) | NYU Langone Health | 1999-08-01 |
| Toremifene in Treating Patients With Ovarian Cancer (NCT00003865) | George Washington University | 1999-07-22 |
| Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors (NCT00004082) | Beth Israel Deaconess Medical Center | 1999-07-01 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer (NCT00004008) | University of Glasgow | 1999-07-01 |
| Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT00004060) | Daiichi Sankyo | 1999-07-01 |
| Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer (NCT00004081) | Beth Israel Deaconess Medical Center | 1999-07-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer (NCT00003386) | Gynecologic Oncology Group | 1999-07-01 |
| Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma (NCT00004066) | Memorial Sloan Kettering Cancer Center | 1999-06-01 |
| SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) (NCT00002960) | Merck Sharp & Dohme LLC | 1999-06-01 |
| ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment (NCT00005645) | Genzyme, a Sanofi Company | 1999-05-01 |
| Methods in Education for Breast Cancer Genetics (NCT00001806) | National Cancer Institute (NCI) | 1999-04-06 |
| Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma (NCT00003778) | National Cancer Institute (NCI) | 1999-04-01 |
| Quality of Life in Survivors of Gynecologic Cancer (NCT00003795) | Gynecologic Oncology Group | 1999-04-01 |
| Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer (NCT00003794) | Gynecologic Oncology Group | 1999-04-01 |
| Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer (NCT00005023) | University of Washington | 1999-03-01 |
| Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT00003385) | Gynecologic Oncology Group | 1999-03-01 |
| Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma (NCT00003308) | Eastern Cooperative Oncology Group | 1999-02-02 |
| ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer (NCT00003892) | NCIC Clinical Trials Group | 1999-02-01 |
| Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer (NCT00003880) | Merck Sharp & Dohme LLC | 1999-02-01 |
| IM-862 in Treating Patients With Recurrent Ovarian Cancer (NCT00003773) | University of Southern California | 1999-02-01 |
| Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer (NCT00004083) | NYU Langone Health | 1999-02-01 |
| Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors (NCT00003518) | Eastern Cooperative Oncology Group | 1999-01-25 |
| Extended Follow-up of Columbia, MO Serum Bank Participants (NCT00340210) | National Cancer Institute (NCI) | 1999-01-14 |
| Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum (NCT00003523) | Gynecologic Oncology Group | 1999-01-01 |
| Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer (NCT00170664) | North Eastern German Society of Gynaecological Oncology | 1999-01-01 |
| Quality-of-Life Assessment in Patients With Ovarian Cancer (NCT00003772) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-01-01 |
| Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy (NCT00004115) | Jonsson Comprehensive Cancer Center | 1998-12-01 |
| Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00004012) | Memorial Sloan Kettering Cancer Center | 1998-12-01 |
| Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer (NCT00003624) | Gynecologic Oncology Group | 1998-12-01 |
| Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors (NCT00025441) | Societe Internationale d'Oncologie Pediatrique | 1998-11-01 |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors (NCT00003926) | Masonic Cancer Center, University of Minnesota | 1998-11-01 |
| Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT00004064) | AltaRex | 1998-11-01 |
| Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer (NCT00003998) | University of Glasgow | 1998-10-01 |
| Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer (NCT00003644) | Gynecologic Oncology Group | 1998-10-01 |
| Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer (NCT00003670) | Eli Lilly and Company | 1998-10-01 |
| Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer (NCT00003450) | University of Texas Southwestern Medical Center | 1998-09-01 |
| Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT00003636) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-09-01 |
| High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery (NCT00004921) | EBMT Solid Tumors Working Party | 1998-09-01 |
| Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma (NCT00003718) | Herbert Irving Comprehensive Cancer Center | 1998-09-01 |
| Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT00019552) | National Cancer Institute (NCI) | 1998-09-01 |
| Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer (NCT00003732) | Rigshospitalet, Denmark | 1998-09-01 |
| Gene Therapy in Treating Patients With Ovarian Cancer (NCT00003588) | National Cancer Institute (NCI) | 1998-09-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer (NCT00003413) | University of Maryland, Baltimore | 1998-09-01 |
| Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation (NCT00003887) | Fred Hutchinson Cancer Center | 1998-08-01 |
| Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer (NCT00652691) | Mayo Clinic | 1998-08-01 |
| Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer (NCT00003378) | Gynecologic Oncology Group | 1998-08-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00003944) | Fox Chase Cancer Center | 1998-08-01 |
| Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing (NCT00165152) | Dana-Farber Cancer Institute | 1998-07-01 |
| High-dose ICE With Amifostine (NCT00003657) | Dana-Farber Cancer Institute | 1998-07-01 |
| Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer (NCT00004037) | Gynecologic Oncology Group | 1998-06-01 |
| Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer (NCT00003695) | Medical Research Council | 1998-05-01 |
| Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer (NCT00003382) | Gynecologic Oncology Group | 1998-05-01 |
| Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00003560) | Herbert Irving Comprehensive Cancer Center | 1998-05-01 |
| Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer (NCT00003449) | University of Southern California | 1998-05-01 |
| Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT00003380) | Gynecologic Oncology Group | 1998-05-01 |
| Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00019461) | National Cancer Institute (NCI) | 1998-04-01 |
| Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy (NCT00003634) | AltaRex | 1998-04-01 |
| Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (NCT00003408) | Cancer Treatment Centers of America | 1998-04-01 |
| Continuation of Follow-up of DES-Exposed Cohorts (NCT00340600) | National Cancer Institute (NCI) | 1998-03-18 |
| Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer (NCT00003322) | Gynecologic Oncology Group | 1998-03-01 |
| Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel (NCT00003569) | Roswell Park Cancer Institute | 1998-03-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors (NCT00003852) | UNICANCER | 1998-03-01 |
| Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00003269) | Scripps Health | 1998-02-01 |
| Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00003358) | Memorial Sloan Kettering Cancer Center | 1998-01-01 |
| Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer (NCT00003763) | Endocyte | 1997-12-08 |
| Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer (NCT00003733) | SmithKline Beecham | 1997-12-01 |
| Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect (NCT00003425) | University of Kentucky | 1997-12-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer (NCT00003297) | Georgetown University | 1997-12-01 |
| S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission (NCT00003120) | SWOG Cancer Research Network | 1997-11-01 |
| Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer (NCT00003135) | The University of Texas Health Science Center, Houston | 1997-11-01 |
| Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors (NCT00003107) | Indiana University | 1997-10-01 |
| Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT00003345) | Memorial Sloan Kettering Cancer Center | 1997-10-01 |
| High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors (NCT00003173) | Memorial Sloan Kettering Cancer Center | 1997-09-01 |
| Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum (NCT00003160) | Theradex | 1997-09-01 |
| Chemotherapy in Treating Patients With Solid Tumors (NCT00003103) | Memorial Sloan Kettering Cancer Center | 1997-08-01 |